Editorial comment: Comparing two different therapies

dc.authorscopusid6701442802
dc.contributor.authorAkdemir O.
dc.date.accessioned2024-06-12T10:28:57Z
dc.date.available2024-06-12T10:28:57Z
dc.date.issued2003
dc.description.abstract[No abstract available]en_US
dc.identifier.endpage339en_US
dc.identifier.issn1302-8723
dc.identifier.issue4en_US
dc.identifier.pmid14675885en_US
dc.identifier.scopus2-s2.0-1542542764en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage338en_US
dc.identifier.urihttps://hdl.handle.net/20.500.14551/17503
dc.identifier.volume3en_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.relation.ispartofAnadolu Kardiyoloji Dergisien_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAntihypertensive Agent; Dipeptidyl Carboxypeptidase Inhibitor; Glyceryl Trinitrate; Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor; Lisinopril; Simvastatin; Antilipemic Agent; Dipeptidyl Carboxypeptidase Inhibitor; Lisinopril; Simvastatin; Blood Flowmetry; Blood Pressure Monitoring; Blood Pressure Regulation; Brachial Artery; Clinical Trial; Diastolic Blood Pressure; Editorial; Endothelium Cell; Endothelium Lesion; Essential Hypertension; Human; Hyperlipidemia; Monotherapy; Nonparametric Test; Pulse Pressure; Statistical Analysis; Systolic Blood Pressure; Vasodilatation; Blood Pressure; Comparative Study; Controlled Clinical Trial; Drug Combination; Drug Effect; Echography; Hypertension; Note; Pathophysiology; Patient Selection; Physiology; Prospective Study; Pulsatile Flow; Randomized Controlled Trial; Angiotensin-Converting Enzyme Inhibitors; Antilipemic Agents; Blood Pressure; Brachial Artery; Drug Therapy, Combination; Humans; Hypertension; Lisinopril; Patient Selection; Prospective Studies; Pulsatile Flow; Randomized Controlled Trials; Simvastatinen_US
dc.titleEditorial comment: Comparing two different therapiesen_US
dc.typeEditorialen_US

Dosyalar